La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Bamboos Health Care Holdings Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Bamboos Health Care Holdings.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Healthcare crescita degli utili	16.2%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Shareholders May Not Be So Generous With Bamboos Health Care Holdings Limited's (HKG:2293) CEO Compensation And Here's Why

Nov 22

Some Investors May Be Worried About Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Aug 20

The Returns On Capital At Bamboos Health Care Holdings (HKG:2293) Don't Inspire Confidence

May 02

Income Investors Should Know That Bamboos Health Care Holdings Limited (HKG:2293) Goes Ex-Dividend Soon

Mar 10

Does Bamboos Health Care Holdings Limited (HKG:2293) Have A Place In Your Dividend Portfolio?

Jan 29

Here's What To Make Of Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Jan 08

Bamboos Health Care Holdings Limited's (HKG:2293) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 18

We Think Bamboos Health Care Holdings's (HKG:2293) Statutory Profit Might Understate Its Earnings Potential

Nov 27

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Bamboos Health Care Holdings non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

SEHK:2293 - Stime future degli analisti e dati finanziari passati (HKD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2023	109	33	35	36	N/A
9/30/2023	119	40	38	39	N/A
6/30/2023	128	47	42	42	N/A
3/31/2023	132	51	39	47	N/A
12/31/2022	136	56	37	53	N/A
9/30/2022	139	57	69	85	N/A
6/30/2022	141	59	100	116	N/A
3/31/2022	144	67	101	109	N/A
12/31/2021	147	75	102	102	N/A
9/30/2021	129	68	76	76	N/A
6/30/2021	111	61	49	49	N/A
3/31/2021	93	47	45	47	N/A
12/31/2020	76	34	41	44	N/A
9/30/2020	76	32	41	44	N/A
6/30/2020	76	31	42	44	N/A
3/31/2020	79	36	39	41	N/A
12/31/2019	83	40	37	37	N/A
9/30/2019	82	40	34	35	N/A
6/30/2019	82	39	32	32	N/A
3/31/2019	83	38	28	28	N/A
12/31/2018	83	38	24	25	N/A
9/30/2018	84	40	23	24	N/A
6/30/2018	85	42	23	24	N/A
3/31/2018	80	39	27	28	N/A
12/31/2017	75	37	32	33	N/A
9/30/2017	70	35	N/A	N/A	N/A
6/30/2017	67	33	N/A	34	N/A
3/31/2017	63	31	N/A	N/A	N/A
12/31/2016	58	29	N/A	31	N/A
9/30/2016	57	28	N/A	N/A	N/A
6/30/2016	54	27	N/A	29	N/A
3/31/2016	53	27	N/A	N/A	N/A
12/31/2015	53	26	N/A	26	N/A
9/30/2015	51	24	N/A	N/A	N/A
6/30/2015	49	22	N/A	18	N/A
3/31/2015	47	16	N/A	N/A	N/A
12/31/2014	43	9	N/A	7	N/A
9/30/2014	41	9	N/A	N/A	N/A
6/30/2014	38	9	N/A	16	N/A
3/31/2014	36	12	N/A	N/A	N/A
12/31/2013	34	16	N/A	21	N/A
9/30/2013	33	15	N/A	N/A	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista 2293 è superiore al tasso di risparmio ( 2.3% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di 2293 cresceranno più velocemente del mercato Hong Kong

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di 2293 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di 2293 cresceranno più rapidamente del mercato Hong Kong.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di 2293 cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di 2293 è previsto essere elevato tra 3 anni

Bamboos Health Care Holdings Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

CEO & Executive Chairman recently bought HK$389k worth of stock

First half 2024 earnings released: EPS: HK$0.043 (vs HK$0.076 in 1H 2023)

Upcoming dividend of HK$0.05 per share

First half dividend of HK$0.05 announced

Bamboos Health Care Holdings Limited Announces Interim Dividend for the Six Months Ended 31 December 2023, Payable on March 22, 2024

Bamboos Health Care Holdings Limited to Report Q2, 2024 Results on Feb 27, 2024

Upcoming dividend of HK$0.037 per share at 10% yield

Bamboos Health Care Holdings (HKG:2293) Is Reducing Its Dividend To HK$0.0375

Full year 2023 earnings released: EPS: HK$0.12 (vs HK$0.15 in FY 2022)

Full year 2023 earnings released: EPS: HK$0.12 (vs HK$0.15 in FY 2022)

Bamboos Health Care Holdings Limited, Annual General Meeting, Nov 28, 2023

Bamboos Health Care Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

Upcoming dividend of HK$0.037 per share at 13% yield

First half 2023 earnings released: EPS: HK$0.077 (vs HK$0.084 in 1H 2022)

Bamboos Health Care Holdings Limited to Report First Half, 2023 Results on Feb 23, 2023

Bamboos Health Care Holdings (HKG:2293) Knows How To Allocate Capital

Upcoming dividend of HK$0.05 per share

CEO & Executive Chairman recently bought HK$130k worth of stock

Bamboos Health Care Holdings Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: EPS: HK$0.15 (vs HK$0.15 in FY 2021)

Bamboos Health Care Holdings Limited to Report Fiscal Year 2022 Results on Sep 27, 2022

First half 2022 earnings released: EPS: HK$0.084 (vs HK$0.049 in 1H 2021)

Bamboos Health Care Holdings (HKG:2293) Is Due To Pay A Dividend Of HK$0.025

Upcoming dividend of HK$0.025 per share

Bamboos Health Care Holdings Limited Announces Change of Company Secretary and Authorised Representative

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Bamboos Health Care Holdings (HKG:2293) Has Announced A Dividend Of HK$0.025

Bamboos Health Care Holdings Limited Declares Interim Dividend for the Six Months Ended December 31, 2021, Payable on 25 March 2022

Bamboos Health Care Holdings Limited to Report First Half, 2022 Results on Feb 22, 2022

Shareholders May Not Be So Generous With Bamboos Health Care Holdings Limited's (HKG:2293) CEO Compensation And Here's Why

Inaugural dividend of HK$0.075 per share

Full year 2021 earnings released: EPS HK$0.15 (vs HK$0.077 in FY 2020)

Investor sentiment improved over the past week

High number of new and inexperienced directors

Some Investors May Be Worried About Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Independent Non-Executive Director Peck Lim Chhoa has left the company

Independent Non-Executive Director Wing Man Ko has left the company

The Returns On Capital At Bamboos Health Care Holdings (HKG:2293) Don't Inspire Confidence

First half 2021 earnings released: EPS HK$0.049 (vs HK$0.042 in 1H 2020)

Bamboos Health Care Holdings Limited Declares Interim Dividend for the Six Months Ended 31 December 2020, Payable on 26 March 2021

Income Investors Should Know That Bamboos Health Care Holdings Limited (HKG:2293) Goes Ex-Dividend Soon

First half 2021 earnings released: EPS HK$0.049 (vs HK$0.042 in 1H 2020)

Bamboos Health Care Holdings Limited to Report First Half, 2021 Results on Feb 23, 2021

New 90-day high: HK$0.88

Does Bamboos Health Care Holdings Limited (HKG:2293) Have A Place In Your Dividend Portfolio?

Here's What To Make Of Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Bamboos Health Care Holdings Limited's (HKG:2293) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

New 90-day low: HK$0.73

We Think Bamboos Health Care Holdings's (HKG:2293) Statutory Profit Might Understate Its Earnings Potential

New 90-day low: HK$0.90

Upcoming Dividend of HK$0.025 Per Share

Full year earnings released - EPS HK$0.077

Full year earnings released - EPS HK$0.077

Bamboos Health Care Holdings Limited to Report Fiscal Year 2020 Results on Sep 18, 2020

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita